High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer

Journal of Surgical Oncology

Volumn 111, Issue 6, 2015, Pages 752-759

  Sugimura, Keijiro ^a   Miyata, Hiroshi ^a   Tanaka, Koji ^a   Takahashi, Tsuyoshi ^a   Kurokawa, Yukinori ^a   Yamasaki, Makoto ^a   Nakajima, Kiyokazu ^a   Takiguchi, Shuji ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chemotherapy; esophageal cancer; macrophage

Indexed keywords

ANTINEOPLASTIC AGENT; CD163 ANTIGEN; CD68 ANTIGEN; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; AGED; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE; ESOPHAGEAL NEOPLASMS; LYMPH NODE METASTASIS; MACROPHAGE; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS;

AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; CHEMOTHERAPY, ADJUVANT; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MACROPHAGES; MALE; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 84928141330     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23881     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Eslick GD,: Epidemiology of esophageal cancer. Gastroenterol Clin North Am 2009; 38.
3. Kollarova H, Machova L, Horakova D, et al.: Epidemiology of esophageal cancer-an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2007; 151: 17-20.
4. Ando N, Iizuka T, Ide H, et al.: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan clinical oncology group study-JCOG9204. J Clin Oncol 2003; 21: 4592-4596.
5. Ando N, Kato H, Igaki H, et al.: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 2011; 19: 68-74.
6. Miyata H, Yamasaki M, Kurokawa Y, et al.: Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011; 59: 461-466.
7. Condeelis J, Pollard JW,: Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124: 263-266.
8. Qian BZ, Pollard JW,: Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141: 39-51.
9. Heusinkveld M, van der Burg SH,: Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011; 9: 216.
10. Benoit M, Desnues B, Mege JL,: Macrophage polarization in bacterial infections. J Immunol 2008; 181: 3733-3739.
11. Mantovani A, Sozzani S, Locati M, et al.: Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
12. Satoh T, Takeuchi O, Vandenbon A, et al.: The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11: 936-944.
13. Linde N, Lederle W, Depner S, et al.: Vascular endothelial growth factor induced skin carcinogenesis depends on recruitment and alternative activation of macrophages. J Pathol 2012; 227: 17-28.
14. Werno C, Menrad H, Weigert A, et al.: Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. Carcinogenesis 2010; 31: 1863-1872.
15. Miyata H, Yoshioka A, Yamasaki M, et al.: Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 2009; 115: 3324-3334.
16. Sobin LH, Compton CC,: TNM seventh edition: What's new, what's changed: Communication from the international union against cancer and the american joint committee on cancer. Cancer 2010; 116: 5336-5339.
17. Miller AB, Hoogstraten B, Staquet M,: Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
18. Society JE,: Japanese classification of esophageal cancer. 10th Tokyo. Japan: Kanehara & Co Ltd; 2008.
19. Hamano R, Miyata H, Yamasaki M, et al.: High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer. Br J Cancer 2012; 106: 1415-1423.
20. Tsutsui S, Yasuda K, Suzuki K, et al.: Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005; 14: 425-431.
21. Nonomura N, Takayama H, Nakayama M, et al.: Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU Int 2011; 107: 1918-1922.
22. Ma J, Liu L, Che G, et al.: The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010; 10: 112.
23. Komohara Y, Hasita H, Ohnishi K, et al.: Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 2011; 102: 1424-1431.
24. Wang XB, Tian XY, Li Y, et al.: Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. J Neurooncol 2012; 106: 43-51.
25. Steidl C, Lee T, Shah SP, et al.: Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N Engl J Med 2010; 362: 875-885.
26. Migita T, Sato E, Saito K, et al.: Differing expression of MMPs-1 and-9 and urokinase receptor between diffuse-and intestinal-type gastric carcinoma. Int J Cancer 1999; 84: 74-79.
27. Koukourakis MI, Giatromanolaki A, Kakolyris S, et al.: Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: Impact on tumour neoangiogenesis and survival. Br J Cancer 1998; 77: 1696-1703.
28. Forssell J, Oberg A, Henriksson ML, et al.: High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007; 13: 1472-1479.
29. Guo SJ, Lin DM, Li J, et al.: Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 2007; 20: 107-116.
30. Shigeoka M, Urakawa N, Nakamura T, et al.: Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci 2013; 104: 1112-1119.
31. Zhang W, Zhu XD, Sun HC, et al.: Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin Cancer Res 2010; 16: 3420-3430.
32. Jinushi M, Chiba S, Yoshiyama H, et al.: Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci USA 2011; 108: 112425-112430.
33. Rolny C, Mazzone M, Tugues S, et al.: HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 2011; 19: 31-44.
34. Nakanishi Y, Nakatsuji M, Seno H, et al.: COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis 2011; 32: 1333-1339.
35. Dijkgraaf EM, Heusinkveld M, Tummers B, et al.: Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res 2013; 73: 12480-12492.
36. Ramprasad MP, Terpstra V, Kondratenko N, et al.: Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci USA 1996; 93: 14833-14838.
37. Huang Y, Snuderl M, Jain RK,: Polarization of tumor-associated macrophages: A novel strategy for vascular normalization and antitumor immunity. Cancer Cell 2011; 19: 1-2.
38. Fabriek BO, Dijkstra CD, van den Berg TK,: The macrophage scavenger receptor CD163. Immunobiology 2005; 210: 153-160.
39. Kioi M, Vogel H, Schultz G, et al.: Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J Clin Invest 2010; 120: 694-705.
40. Ahn GO, Tseng D, Liao CH, et al.: Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA 2010; 107: 8363-8368. grGo.